Collaboration with industry

Collaboration with the industry for mutual exchange of knowledge and ideas is important for Genomic Medicine Sweden. Industrial collaboration contributes to the continued development of Genomic Medicine Sweden and strengthens the opportunities for new advanced diagnostics and treatments to be developed and introduced in healthcare.

Two women and two men talking in front of a laptop.

The GMS working group for innovation and industry collaboration is the contact point for the business community. Our mission is to promote business collaboration and innovation by pursuing strategic collaboration issues and supporting the implementation of collaboration activities.

How does GMS interact with industry?

Collaboration with industry can include all areas of activity within GMS. Collaborative activities are based on mutual interests and needs. These may include various forms of information and dialogue meetings, seminars and workshops for increased knowledge exchange and identification of areas for future joint research and development projects.

Current activities

  • Identification of common interests and value-creating activities through dialogue with a variety of actors.
  • During the winter of 2021/2022, together with the industry organizations LIF, Swedish Medtech, SwedenBIO and Swedish Labtech, we will design a framework for business collaboration. The framework aims to support and simplify collaboration with GMS.

Welcome to contact us with questions about innovation and business collaboration.


Kontakt Innovation- och företagssamverkan

By filling in this form, you agree that Region Skåne processes your personal information. You can find more information here:

Welcome to contact us, you can reach us through the above contact form.


Maria Johansson. Photo: private

Therese Fagerqvist: Photo: Mikael Wallerstedt

Introduction collaboration

GMS is a national initiative in genomic and precision medicine where collaboration plays a key role. Together with healthcare providers, academia, the private sector and patient organizations we create a unique foundation for strengthening Swedish healthcare, research, innovation and life-science in precision medicine.